Education Library

Junya Ako, MD, presents outcomes in AMI cardiogenic shock from Japan's J-PVAD study at TCT 2022.

Jonathan Hill, MD, discusses influential trials in high-risk PCI that are shaping the future of ischemic heart failure therapy.

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.

Aditya Bharadwaj, MD, an investigator for the RESTORE EF study, presents a case study epitomizing the results from the trial.

Mitul Patel, MD, discusses the RESTORE EF study and a successful case of improved ejection fraction with complete revascularization.

Jason Wollmuth, MD, describes best practice techniques for Impella-supported complete revascularization in a RESTORE EF case.

Babar Basir, MD, highlights key concepts in the NCSI protocol that will be studied in the RECOVER IV randomized controlled trial.

William O’Neill, MD, discusses the need for designing programs to improve outcomes in patients with AMI cardiogenic shock.

Aditya Bharadwaj, MD, walks through the first PROTECT IV case enrolled at Loma Linda University Health Care in California.

Babar Basir, MD, discusses how hemodynamics can help clinicians decide whether to use mechanical circulatory support (MCS) in patients undergoing high-risk PCI.

Mihas Kodenchery, MD, and Laura Rodriguez, NP, discuss the low mortality and low complication rates in their high-volume high-risk PCI practice.
 

William O’Neill, MD, discusses the current state of mechanical circulatory support for AMI cardiogenic shock.
 

This case study describes how escalation of support to Impella 5.5 with SmartAssist enabled heart recovery in a 33-year-old woman with postpartum myocarditis.
 

Amir Kaki, MD, describes best practices and practical considerations for optimizing care of patients with AMI cardiogenic shock prior to leaving the cath lab.

Bobby Yeh, MD, discusses how real-world evidence factors into treatment decisions made every day in clinical practice.